Reply to M. Lv et al

Anna C Singleton; Rebecca Raeside; Karice K Hyun; Stephanie R Partridge; Gian Luca Di Tanna; Nashid Hafiz; Qiang Tu; Justin Tat-Ko; Stephanie Che Mun Sum; Kerry A Sherman; Elisabeth Elder; Julie Redfern

doi:10.1200/JCO.22.01571

Reply to M. Lv et al

Anna C Singleton, Rebecca Raeside, Karice K Hyun, Stephanie R Partridge, Gian Luca Di Tanna, Nashid Hafiz, Qiang Tu, Justin Tat-Ko, Stephanie Che Mun Sum, Kerry A Sherman, Elisabeth Elder, Julie Redfern

Research output: Contribution to journal › Letter › Research

Abstract

We thank Lv et al1 for their correspondence in response to our article.2 We agree that the utmost rigor and scientific quality ought to be sought when conducting systematic reviews and meta-analyses. We also agree that the proliferation of electronic health interventions3 calls for a thorough evaluation of evidence to assure results will be valuable for researchers, health professionals, and the growing population of people living with and beyond cancer.

Original language	English
Pages (from-to)	144-145
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	41
Issue number	1
DOIs	https://doi.org/10.1200/JCO.22.01571
Publication status	Published - 1 Jan 2023
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.22.01571

Cite this

@article{cbe8343065ee4ffcb899a4319ad9772c,

title = "Reply to M. Lv et al",

abstract = "We thank Lv et al1 for their correspondence in response to our article.2 We agree that the utmost rigor and scientific quality ought to be sought when conducting systematic reviews and meta-analyses. We also agree that the proliferation of electronic health interventions3 calls for a thorough evaluation of evidence to assure results will be valuable for researchers, health professionals, and the growing population of people living with and beyond cancer.",

author = "Singleton, {Anna C} and Rebecca Raeside and Hyun, {Karice K} and Partridge, {Stephanie R} and {Di Tanna}, {Gian Luca} and Nashid Hafiz and Qiang Tu and Justin Tat-Ko and Sum, {Stephanie Che Mun} and Sherman, {Kerry A} and Elisabeth Elder and Julie Redfern",

year = "2023",

month = jan,

day = "1",

doi = "10.1200/JCO.22.01571",

language = "English",

volume = "41",

pages = "144--145",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "AMER SOC CLINICAL ONCOLOGY",

number = "1",

}

TY - JOUR

T1 - Reply to M. Lv et al

AU - Singleton, Anna C

AU - Raeside, Rebecca

AU - Hyun, Karice K

AU - Partridge, Stephanie R

AU - Di Tanna, Gian Luca

AU - Hafiz, Nashid

AU - Tu, Qiang

AU - Tat-Ko, Justin

AU - Sum, Stephanie Che Mun

AU - Sherman, Kerry A

AU - Elder, Elisabeth

AU - Redfern, Julie

PY - 2023/1/1

Y1 - 2023/1/1

N2 - We thank Lv et al1 for their correspondence in response to our article.2 We agree that the utmost rigor and scientific quality ought to be sought when conducting systematic reviews and meta-analyses. We also agree that the proliferation of electronic health interventions3 calls for a thorough evaluation of evidence to assure results will be valuable for researchers, health professionals, and the growing population of people living with and beyond cancer.

AB - We thank Lv et al1 for their correspondence in response to our article.2 We agree that the utmost rigor and scientific quality ought to be sought when conducting systematic reviews and meta-analyses. We also agree that the proliferation of electronic health interventions3 calls for a thorough evaluation of evidence to assure results will be valuable for researchers, health professionals, and the growing population of people living with and beyond cancer.

U2 - 10.1200/JCO.22.01571

DO - 10.1200/JCO.22.01571

M3 - Letter

C2 - 36122319

SN - 0732-183X

VL - 41

SP - 144

EP - 145

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 1

ER -

Reply to M. Lv et al

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this